$BDX
Becton, Dickinson and
Analysts are split 0 bullish to 1 bearish right now, so the read is stable. We track every change on this ticker and keep the clip behind each.
BDX · LATEST CLOSE
—
1 NEW ANALYSTS· 7D0 bull · 1 bearon record · distinct current stance0takes tracked · cumulative, incl. history
STANCE · 7D
0 bull · 1 bear on record. Movement, not a recommendation.
We track what changes on this ticker: flips, new takes, consensus shifts. We keep the clip behind each, and never call a winner.
The case on BDX, argument by argument
We group takes by the argument being made, so you read reasoning, not a pile of identical calls. Open any thesis to see each analyst's claim, its evidence, and the clip. Both sides are kept; neither is summarized into a house view.
The bull case0 analysts · 0 holds
One analyst can hold several arguments, so holds can exceed analysts.
No bull argument on record yet.
The bear case1 analysts · 1 holds
One analyst can hold several arguments, so holds can exceed analysts.
Debt Load Dividend Risk
Debt Load Dividend Risk
FAST Graphs
“BDX is a cheap, predictable, cash-draining medical device franchise with a heavy debt load, but a 45-year dividend growth record.”
Why
cheap, predictable, cash draining medical device franchise saddled with a heavy debt load
total debt was 18 billion in fiscal year '21, dipped to 16 billion in '22, spiked to 20 billion in 2024.
Risk
45 years of dividend increases. It's a dividend aristocrat approaching dividend king
1 analyst has covered BDX so far…
Stay on top of $BDX
TRIAL · 30D